No profile data available.
Nano-X Imaging Ltd. (NNOX) is a healthcare company in the additional walk-in testing services industry, based in Petah Tikva, Israel, with about 197 full-time employees.
It reported revenue of $13.02 million for fiscal year 2025, up 15.4% from fiscal year 2024, and net income of -$75.02 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $4.16 million, up 36.7% from a year before. Its largest business segment, Radiology Services, brought in 89% of segment revenue in fiscal year 2025; Unites States was the largest region with 98%. Its market capitalization was $42.26 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox.
Nano-X Imaging reported $13.02 million in revenue for fiscal year 2025, up 15.4% from $11.28 million in fiscal year 2024. In Q2 2026 revenue was $4.16 million.
Radiology Services, with $11.59 million or 89% of segment revenue in fiscal year 2025. Next: AI and Software Solutions (7%) and Nanox.ARC (4%).
Unites States: 98% of revenue by region in fiscal year 2025, followed by Foreign (2%).
$42.26 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional walk-in testing services) include RadNet, Inc. (RDNT), CompuMed, Inc. (CMPD), Leveljump Healthcare Corp. (JMPHF).